Randomized clinical trials in periodontology: ethical considerations

Area of Science:

• Clinical research ethics
• Trial design and methodology

Background:

• Ethical clinical trials necessitate an initial assertion of equipoise, meaning no definitive evidence favors one treatment over another.
• This equipoise can be theoretical (lack of superiority data) or clinical (expert disagreement on superiority).
• Placebo controls pose ethical challenges, especially with irreversible outcomes, when preliminary data suggest an active agent's superiority.

Purpose of the Study:

• To outline the ethical prerequisites for initiating clinical trials.
• To address the specific ethical considerations of using placebo controls in clinical research.
• To emphasize the importance of participant rights and data integrity in trial design.

Main Methods:

• Discussion of theoretical and clinical equipoise as ethical foundations.
• Explanation of informed consent procedures, including randomization and blinding.
• Emphasis on the role of data and safety monitoring boards and pre-defined stopping rules.
• Inclusion criteria for women and minority populations.
• Balancing validity, generalizability, and efficiency in trial design.

Main Results:

• Ethical justification hinges on establishing equipoise prior to trial commencement.
• Informed consent must detail randomization and blinding procedures.
• Data and safety monitoring boards are crucial for ongoing trial oversight.
• Inclusion of diverse populations is an ethical imperative.
• Trial design must balance scientific rigor with practical and ethical considerations.

Conclusions:

• Establishing and maintaining equipoise is fundamental for ethical clinical trial initiation.
• Transparent informed consent and robust monitoring are essential for participant protection.
• Inclusive trial design ensures broader applicability and ethical integrity.
• Careful consideration of validity, generalizability, and efficiency optimizes trial outcomes.